Jörg B. Engel
Department of Gynecology and Obstetrics
University Medical Center Regensburg
93057
Regensburg
Germany
Name/email consistency: high
- Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH). Engel, J.B., Schally, A.V., Buchholz, S., Seitz, S., Emons, G., Ortmann, O. Arch. Gynecol. Obstet. (2012)
- Peptidomimetic GnRH Antagonist AEZS-115 Inhibits the Growth of Ovarian and Endometrial Cancer Cells. Engel, J.B., Hahne, J.C., Häusler, S.F., Meyer, S., Segerer, S.E., Diessner, J., Dietl, J., Honig, A. Anticancer Res. (2012)
- Induction of programmed cell death by inhibition of AKT with the alkylphosphocholine perifosine in in vitro models of platinum sensitive and resistant ovarian cancers. Engel, J.B., Schönhals, T., Häusler, S., Krockenberger, M., Schmidt, M., Horn, E., Köster, F., Dietl, J., Wischhusen, J., Honig, A. Arch. Gynecol. Obstet. (2011)
- Cervical endometriosis associated with malignant pleural mesothelioma mimicking cervical cancer--Occam's razor or the "third man". Engel, J.B., Heuer, S., Segerer, S., Rauthe, S., Dietl, J., Hönig, A. Fertil. Steril. (2011)
- Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibition. Engel, J.B., Schönhals, T., Weidler, C., Häusler, S., Krockenberger, M., Rieger, L., Dietl, J., Wischhusen, J., Honig, A. Oncol. Rep. (2009)
- Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation. Engel, J.B., Honig, A., Schönhals, T., Weidler, C., Häusler, S., Krockenberger, M., Grunewald, T.G., Dombrowski, Y., Rieger, L., Dietl, J., Wischhusen, J. Eur. J. Obstet. Gynecol. Reprod. Biol. (2008)
- Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study. Engel, J.B., Audebert, A., Frydman, R., Zivny, J., Diedrich, K. Eur. J. Obstet. Gynecol. Reprod. Biol. (2007)
- Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones. Engel, J.B., Schally, A.V., Dietl, J., Rieger, L., Hönig, A. Mol. Pharm. (2007)
- Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Engel, J.B., Schally, A.V. Nature Clinical Practice. Endocrinology & Metabolism (2007)
- GnRH agonists and antagonists in assisted reproduction: pregnancy rate. Engel, J.B., Griesinger, G., Schultze-Mosgau, A., Felberbaum, R., Diedrich, K. Reprod. Biomed. Online (2006)
- Extrapituitary effects of GnRH antagonists in assisted reproduction: a review. Engel, J.B., Riethmüller-Winzen, H., Diedrich, K. Reprod. Biomed. Online (2005)
- Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility study. Engel, J.B., Olivennes, F., Fanchin, R., Frydman, N., Le Dû, A., Blanchet, V., Frydman, R. Reprod. Biomed. Online (2003)
- Inhibin B on the day of HCG-administration is a predictive factor for failure in assisted reproduction cycles. Engel, J.B., Felberbaum, R.E., Junge, K., Reissmann, T., Diedrich, K. Arch. Gynecol. Obstet. (2003)
- Clomiphene-induced LH surges and cetrorelix. Engel, J.B., Felberbaum, R.E., Eilers, W., Polack, S., Ortmann, O., Diedrich, K. Reprod. Biomed. Online (2002)









